MedTrace Logo

Warfarin Versus Aspirin Recurrent Stroke Study

NCT00027066 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2206

Last updated 2011-06-17

No results posted yet for this study

Summary

The goal of this study is to compare aspirin to warfarin for the prevention of recurrent stroke.

Conditions

Interventions

DRUG

Active Aspirin

325mg tablet daily

DRUG

Active Warfarin

2mg scored tablet daily

DRUG

Aspirin placebo

325mg aspirin placebo pill

DRUG

Warfarin placebo

2mg scored placebo tablet

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • J. P. Mohr, M.D. · Columbia University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-06-30
Primary Completion
2000-06-30
Completion
2001-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00027066 on ClinicalTrials.gov